Insulet PODD
NASDAQ PODD
$149.26 -2.25 (-1.49%)
At close: Aug 20, 2026 · 2:16 PM UTC

Insulet (PODD) Total Current Liabilities (2010 - 2026)

Insulet's (PODD) quarterly Total Current Liabilities came in at $687.5 million in Q1 2026, up 32.11% YoY from $520.4 million in Q1 2025, and up 1.09% on a QoQ basis from $680.1 million in Q4 2025.

Insulet (PODD) Total Current Liabilities (2010 - 2026) Analysis & Trends

Insulet (PODD) has 17 years of Total Current Liabilities data on file, last reported at $687.5 million in Q1 2026.

  • Quarterly Total Current Liabilities rose 32.11% year-over-year to $687.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $687.5 million (up 32.11% YoY) and the FY2025 annual result came in at $680.1 million, up 28.71% from the prior year.
  • Total Current Liabilities improved to $687.5 million in Q1 2026, from $680.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.0 billion in Q2 2025 to a low of $215.0 million in Q1 2022.
  • A 5-year average of $494.3 million and a median of $451.4 million in 2023 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Current Liabilities increased 12.14% — and 2025, when it soared 107.84%.
  • Tracing PODD's Total Current Liabilities over 5 years: stood at $364.7 million in 2022, then increased by 23.72% to $451.2 million in 2023, then climbed by 17.11% to $528.4 million in 2024, then climbed by 28.71% to $680.1 million in 2025, then increased by 1.09% to $687.5 million in 2026.
  • The last three Total Current Liabilities figures came in at $687.5 million (Q1 2026), $680.1 million (Q4 2025), and $647.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Abbott Laboratories 199.61 Bn 194.01 Bn 7.27 Bn 17.81 Bn
2 Stryker 127.81 Bn 124.34 Bn 4.50 Bn 6.68 Bn
3 Medtronic 119.04 Bn 109.82 Bn 6.41 Bn 11.66 Bn
4 Boston Scientific 73.68 Bn 73.14 Bn 3.85 Bn 6.43 Bn
5 Edwards Lifesciences 51.96 Bn 47.71 Bn 1.35 Bn 1.51 Bn
6 Dexcom 34.36 Bn 32.41 Bn 830.00 Mn 2.36 Bn
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn 8.30 Bn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 8.63 Bn
9 Steris 23.06 Bn 22.58 Bn 684.20 Mn 1.28 Bn
10 Insulet 10.34 Bn 9.81 Bn 562.60 Mn 744.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 744.20 Mn
Mar 31, 2026 687.50 Mn
Dec 31, 2025 680.10 Mn
Sep 30, 2025 647.70 Mn
Jun 30, 2025 1.01 Bn
Mar 31, 2025 520.40 Mn
Dec 31, 2024 528.40 Mn
Sep 30, 2024 506.20 Mn
Jun 30, 2024 486.00 Mn
Mar 31, 2024 432.40 Mn
Dec 31, 2023 451.20 Mn
Sep 30, 2023 451.40 Mn
Jun 30, 2023 425.00 Mn
Mar 31, 2023 383.30 Mn
Dec 31, 2022 364.70 Mn
Sep 30, 2022 334.20 Mn
Jun 30, 2022 279.30 Mn
Mar 31, 2022 215.00 Mn
Dec 31, 2021 228.80 Mn
Sep 30, 2021 228.60 Mn